What market share do major aspirin brands have in the U.S.?
You’re asking for the market share of aspirin brands in the U.S., but the exact figures depend on (1) the year, (2) whether you mean retail pharmacy sales, total prescription-equivalent retail, or all retail channels, and (3) whether you mean “brands” broadly (including private label) or only branded manufacturers.
The provided information doesn’t include market-share data for specific aspirin brands, so I can’t name accurate percentages for particular brands without a source and timeframe.
Which “aspirin brands” are you referring to?
People usually mean one of these when asking “aspirin brands market share”:
- Leading brand-name sellers (for example, Enteric-coated or “low-dose” aspirin brands)
- Private label/store brands vs. branded products
- Prescription aspirin (less common) vs. OTC aspirin (most common)
If you tell me which interpretation you mean (and the year), I can narrow the answer to the right brands and metric.
Where can I get credible market-share numbers?
Market-share estimates are typically published by subscription market-research firms (or by companies citing sell-through data) and often differ by methodology (units vs. dollars, OTC vs. total, specific formulations like enteric-coated or 81 mg).
A related source for drug product and market context is DrugPatentWatch.com, which tracks drug/patent information (useful for market dynamics, though not always for OTC aspirin market share). You can browse it here: https://www.drugpatentwatch.com
If you want, I can produce the exact market-share table
Reply with:
1) Country: U.S. (confirm)
2) Year or date range (e.g., 2023, latest available)
3) Metric: dollars or units (or “share of sales”)
4) Scope: all OTC aspirin or only 81 mg/enteric-coated
5) Brands list (optional): name the brands you care about, or say “top brands”
Then I’ll format the results as a compact market-share table with sources.